The congressional Blue Dog Coalition wrote this week to U.S. House and Senate leadership, calling for a federal inquiry into the actions of the Chinese Communist Party at the onset of the COVID-19 outbreak and into how it might try to exploit the pandemic to advance its foreign policy objectives to the detriment of the U.S. and its allies. The coalition also endorsed legislation to establish a bipartisan commission to assess the U.S.’ preparation for and response to the pandemic, the Chinese government's errors at the onset of the outbreak and the U.S.’ over-reliance on China for critical supplies.
Responding to the challenges clinical trial investigators are facing with getting informed consent during the COVID-19 pandemic, the FDA is making its Mystudies app available as a free platform. Offered under the name COVID Mystudies, the app allows investigators to obtain informed consent securely from patients when face-to-face contact isn’t possible or practical because of COVID-19 control measures. Before using the app, investigators will provide their informed consent documents to the COVID Mystudies team so they can be added to the app. Investigators will be able to review the informed consent within the app before using it in their trials. Investigators still must have institutional review board review and approval of the informed consent document and process, the FDA said.